Gil Lewitus

Gil Lewitus is currently working as a Medical Affairs Manager at Medison Pharma and as a Scientific Advisor at myAir. Previously, Gil served as the Chief Scientific Officer at CaVnox, where Gil led the development of a cannabinoids-based cancer treatment. With a background in neuroimmunology and neurobiology, Gil has extensive experience in research and drug development in both academic and industry settings.